Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Broderick

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Frontiers in Neurology|July 9, 2020
Blood Pressure Target in Acute Stroke to Reduce HemorrhaGe After Endovascular Therapy: The Randomized BP TARGET Study ProtocolMikael Mazighi, Julien Labreuche, Sebastien Richard, et al.
JAMA|July 13, 2018
Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical TrialPooja Khatri, Dawn O Kleindorfer, Thomas Devlin, et al.
Stroke|September 6, 2008
The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trialArthur M Pancioli, Joseph Broderick, Thomas Brott, et al.
Plos One|March 25, 2015
Lessons learned from whole exome sequencing in multiplex families affected by a complex genetic disorder, intracranial aneurysmJanice L Farlow, Hai Lin, Laura Sauerbeck, et al.
Journal of the American Heart Association|June 21, 2024
Clinical Trial Exclusion Criteria Affect Trial Inclusivity by Race and SexRobert J Stanton, Yasmin N Aziz, Heidi Sucharew, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 4, 2019
Randomization of endovascular treatment with stent-retriever and/or thromboaspiration versus best medical therapy in acute ischemic stroke due to large vessel occlusion trial: Rationale and designRaul G Nogueira, Fabricio O Lima, Octávio M Pontes-Neto, et al.
The Lancet. Neurology|March 1, 2021
Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trialMikael Mazighi, Sebastien Richard, Bertrand Lapergue, et al.
JAMA Neurology|October 4, 2017
Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical TrialXia Wang, Thompson G Robinson, Tsong-Hai Lee, et al.
The New England Journal of Medicine|September 4, 2024
Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic StrokeOpeolu Adeoye, Joseph Broderick, Colin P Derdeyn, et al.
Stroke|August 8, 2013
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statementOsama O Zaidat, Albert J Yoo, Pooja Khatri, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Frontiers in Neurology|July 9, 2020
Blood Pressure Target in Acute Stroke to Reduce HemorrhaGe After Endovascular Therapy: The Randomized BP TARGET Study ProtocolMikael Mazighi, Julien Labreuche, Sebastien Richard, et al.
JAMA|July 13, 2018
Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical TrialPooja Khatri, Dawn O Kleindorfer, Thomas Devlin, et al.
Stroke|September 6, 2008
The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trialArthur M Pancioli, Joseph Broderick, Thomas Brott, et al.
Plos One|March 25, 2015
Lessons learned from whole exome sequencing in multiplex families affected by a complex genetic disorder, intracranial aneurysmJanice L Farlow, Hai Lin, Laura Sauerbeck, et al.
Journal of the American Heart Association|June 21, 2024
Clinical Trial Exclusion Criteria Affect Trial Inclusivity by Race and SexRobert J Stanton, Yasmin N Aziz, Heidi Sucharew, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 4, 2019
Randomization of endovascular treatment with stent-retriever and/or thromboaspiration versus best medical therapy in acute ischemic stroke due to large vessel occlusion trial: Rationale and designRaul G Nogueira, Fabricio O Lima, Octávio M Pontes-Neto, et al.
The Lancet. Neurology|March 1, 2021
Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trialMikael Mazighi, Sebastien Richard, Bertrand Lapergue, et al.
JAMA Neurology|October 4, 2017
Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical TrialXia Wang, Thompson G Robinson, Tsong-Hai Lee, et al.
The New England Journal of Medicine|September 4, 2024
Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic StrokeOpeolu Adeoye, Joseph Broderick, Colin P Derdeyn, et al.
Stroke|August 8, 2013
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statementOsama O Zaidat, Albert J Yoo, Pooja Khatri, et al.
Pageof 10